title: Lipid composition of circulating multiple-modified low density lipoprotein.
abstract: Atherogenic modified low- density lipoprotein (LDL) induces pronounced accumulation of cholesterol and lipids in the arterial wall, while native LDL seems to lack such capability. Therefore, modified LDL appears to be a major causative agent in the pathogenesis of atherosclerosis. Possible modifications of LDL particles include changes in size and density, desialylation, oxidation and acquisition of negative charge. Total LDL isolated from pooled plasma of patients with coronary atherosclerosis, as well as from healthy subjects contains two distinct subfractions: normally sialylated LDL and desialylated LDL, which can be isolated by binding to a lectin affinity column. We called the desialylated LDL subfraction circulating modified LDL (cmLDL). In this study, we focused on lipid composition of LDL particles, analysing the total LDL preparation and two LDL subfractions: cmLDL and native LDL. The composition of LDL was studied using thin-layer chromatography. We found that cmLDL subfraction had decreased levels of free and esterified cholesterol, triglycerides, phospholipids (except for lysophosphatidylcholine) and sphingomyelin in comparison to native LDL. On the other hand, levels of mono-, and diglycerides, lysophosphatidylcholine and free fatty acids were higher in cmLDL than in native LDL. Our study demonstrated that lipid composition of cmLDL from atherosclerotic patients was altered in comparison to healthy subjects. In particular, phospholipid content was decreased, and free fatty acids levels were increased in cmLDL. This strengthens the hypothesis of multiple modification of LDL particles in the bloodstream and underscores the clinical importance of desialylated LDL as a possible marker of atherosclerosis progression.
authors: Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315, Moscow, Russia.
authors: E R
authors: ER
authors: Zakiev
authors: Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315, Moscow, Russia.
authors: V N
authors: VN
authors: Sukhorukov
authors: Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315, Moscow, Russia.
authors: A A
authors: AA
authors: Melnichenko
authors: Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315, Moscow, Russia.
authors: I A
authors: IA
authors: Sobenin
authors: Department of Development and Regeneration, KU Leuven, 3000, Leuven, Belgium.
authors: E A
authors: EA
authors: Ivanova
authors: Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315, Moscow, Russia. a.h.opexob@gmail.com.|Institute for Atherosclerosis Research, Skolkovo Innovative Center, 121609, Moscow, Russia. a.h.opexob@gmail.com.
authors: A N
authors: AN
authors: Orekhov
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D002784:Cholesterol / Q000032:analysis / Q000097:blood; D002788:Cholesterol Esters / Q000032:analysis / Q000097:blood; D003324:Coronary Artery Disease / Q000097:blood*; D005260:Female; D006801:Humans; D008077:Lipoproteins, LDL / Q000032:analysis / Q000097:blood* / Q000737:chemistry*; D008244:Lysophosphatidylcholines / Q000032:analysis; D008297:Male; D008875:Middle Aged; D010713:Phosphatidylcholines / Q000032:analysis; D010714:Phosphatidylethanolamines / Q000032:analysis; D013109:Sphingomyelins / Q000032:analysis
chemical_list: D002788:Cholesterol Esters; D008077:Lipoproteins, LDL; D008244:Lysophosphatidylcholines; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D013109:Sphingomyelins; C483858:phosphatidylethanolamine; D002784:Cholesterol
keywords: Atherosclerosis; LDL; LDL modification; Lipid composition of LDL; Low density lipoprotein